Jon Clarke writes, “As an avid cyclist and physics teacher, I had a tattoo a few months ago on my calf, and wondered whether that would fit with your archive. Having been given a cycle computer a year ago, I was frustrated and surprised that no matter how hard I cycled–on a level road without a tailwind or fast-moving large vehicle to shadow–I could never reach the UK speed limit in built-up areas (30mph). After some thought, I concluded that the dominant effect, and therefore limitation, was the power required to overcome aerodynamic drag for turbulent flow.”

In this tattoo, v is the speed of a bicyclist, and P is the rate at which muscles have to do work in order to overcome air resistance. If you double your speed, you have to work eight times harder. It is, in other words, a tattoo of human limitation.

You can see the rest of the Science Tattoo Emporium here or in my book, Science Ink: Tattoos of the Science Obsessed.

Originally published June 30, 2013. Copyright 2013 Carl Zimmer.

The New York Times, June 30, 2013

Link

If you are still waiting for Swarmageddon to break out in your backyard, it is time to stop. The great cicada invasion is winding down for 2013, and it will not be back for another 17 years.

After dwelling in the ground since 1996, the insects began to emerge in May from North Carolina to the Hudson River Valley. In yards, forests and fields up and down the coast, they trilled by the billions, mated, laid their eggs in branches and left exoskeletons on bushes and walkways. Now their song is fading.

But while many people were kept up at night by the roar of this arthropod flash mob, others were left to wonder what all the fuss was about.

Continue reading “Swan Song for Cicadas, but Many Missed the Show” →

As you can tell from my recent posts, I am a bit obsessed about cancer–or more specifically something you might call the natural history of cancer. Cancers in the animal kingdom can get very strange–even giving rise to what I would call new species. Earlier this month, I gave a public talk in San Francisco as part of the International Evolution and Cancer Conference. The video is now up. I hope you find these strange cancers as spookily fascinating as I do.

In case the slides are hard to see, I’ve uploaded them via Slide Share:

Zimmer cancer 2013 talk from Carl Zimmer

Originally published June 27, 2013. Copyright 2013 Carl Zimmer.

A number of the newest cancer drugs can give a few months of extra life to people in advanced stages of the disease. The drugs attack the cancer cells with pinpoint accuracy and wipe out the tumors. And then, months later, the tumors come right back. In my “Matter” column today, I take a look at the work of cancer biologists and evolutionary biologists to understand how this rebound happens, and how doctors might stop it. Check it out.

Originally published June 27, 2013. Copyright 2013 Carl Zimmer.

The New York Times, June 27, 2013

Link

Bert Vogelstein, a cancer geneticist at Johns Hopkins University, says he is haunted by three pictures.

The first shows a man’s upper body studded with large melanomas. The second shows what happened when the man took a drug called vemurafenib. Vemurafenib belongs to a relatively new class of drugs, called targeted cancer therapy. Unlike earlier chemotherapy drugs, they attack specific molecules found only in cancer cells. In response to the vemurafenib, the tumors shrank in a matter of weeks, to the point that the man’s skin looked smooth and healthy.

Continue reading “Studying Tumors Differently, in Hopes of Outsmarting Them” →